Westchester Capital Management (New York)’s Zura Bio ZURA Stock Holding History

Westchester Capital Management (New York)’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-254,044	Closed	-$2.59M	–	382
2022 Q4	$2.59M	Hold	254,044	–	–	0.07%	260
2022 Q3	$2.55M	Buy	+254,044	New	+$2.54M	0.07%	239

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Westchester Capital Management (New York)'s ZURA Position: Q1 2023 in Review

Westchester Capital Management (New York) sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 254,044 shares — an estimated $2.59M sold.

Westchester Capital Management (New York) first reported a position in ZURA in Q3 2022 and held it in 2 quarters. The position peaked at $2.59M in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Westchester Capital Management (New York) reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 254,044 Zura Bio shares in Q1 2023, an estimated $2.59M.
Westchester Capital Management (New York) first reported a position in Zura Bio in Q3 2022 and held it in 2 quarters.
Westchester Capital Management (New York)'s Zura Bio position peaked at $2.59M in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2023, filed 15 May 2023.